Developing vaccines and treatments for deadly henipaviruses.
Advancement of Vaccines and Therapies for Henipaviruses
This study is working on making vaccines and treatments for henipaviruses like Nipah and Hendra, which can be dangerous for people and animals, to help protect those at risk and provide care during outbreaks.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Henry M. Jackson Fdn for the Adv Mil/med NIH-funded |
| Lab location | 1 site (Bethesda, United States) |
| Project ID | NIH-10581491 on NIH RePORTER |
What this research studies
This research focuses on creating effective vaccines and therapies for henipaviruses, specifically Nipah and Hendra, which pose significant health risks to both humans and animals. The project aims to develop preventive vaccines for high-risk individuals and postexposure treatments that could be used during outbreaks or biological attacks. Researchers are investigating the glycoproteins of these viruses to generate neutralizing antibodies, which are crucial for vaccine efficacy. The approach includes synthetic production of the viruses to better understand their biology and develop effective countermeasures.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals at high risk of exposure to henipaviruses, such as lab workers and first responders.
Not a fit: Patients who are not at risk of exposure to henipaviruses or those with existing immunity to these viruses may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the first approved vaccines and treatments for henipavirus infections, significantly reducing mortality rates during outbreaks.
How similar studies have performed: Previous research has shown promise in developing vaccines and therapies for similar viral infections, indicating a potential for success in this area as well.
Where this research is happening
Bethesda, United States
- Henry M. Jackson Fdn for the Adv Mil/med — Bethesda, United States (Active)
Researchers
- Principal investigator: Broder, Christopher C — Henry M. Jackson Fdn for the Adv Mil/med
- Study coordinator: Broder, Christopher C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.